Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04751617
Status:
UNKNOWN
Last Update Posted:
2021-02-12
First Post:
2021-02-05
Brief Title:
Pulmonary Rehabilitation of Patients With a History of COVID-19
Sponsor:
University of Rzeszow
Organization:
University of Rzeszow
Study Overview
Official Title:
Impact of Pulmonary Rehabilitation on Quality of Life Body Composition and Respiratory Function of Patients With a History of COVID-19
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the impact of pulmonary rehabilitation on quality of life body composition and respiratory function in patients with a history of COVID-19
Detailed Description:
In December 2019 a novel coronavirus SARS-CoV-2 appeared causing a wide range of symptoms mainly respiratory infection In March 2020 the World Health Organization WHO declared Coronavirus Disease 2019 COVID-19 a pandemic COVID-19 has spread rapidly over several months affecting patients across all age groups and geographic areas The disease has a diverse course patients may range from asymptomatic to those with respiratory failure complicated by acute respiratory distress syndrome
The main objective of this study is to assess the impact of pulmonary rehabilitation on quality of life body composition and respiratory function in patients with a history of COVID-19
The patients after COVID-19 will be included in the pulmonary rehabilitation protocol The duration of rehabilitation will depend on the patients condition from 7 to 14 days
Measurements
quality of life WHOQoL-BREF
body composition bioelectrical impedance analysis BC-420 MA Tanita
weight height and BMI
spirometry Spirometr PNEUMO abcMED
diffusion lung capacity for carbon monoxide LUNGTEST 1000
morphology CRP D-Dimer WBC and gasometry pCO2 pO2
chest computed tomography CT
These parameters will be recorded before the first day of rehabilitation baseline after completion of rehabilitation protocol and three months after completion the rehabilitation protocol A change in evaluated parameters will be assessed
This will be a prospective interventional non-randomized study All patients will be enrolled by Podkarpackie Center for Lung Diseases in Rzeszów
The main objective of this study is to assess the impact of pulmonary rehabilitation on quality of life body composition and respiratory function in patients with a history of COVID-19
The patients after COVID-19 will be included in the pulmonary rehabilitation protocol The duration of rehabilitation will depend on the patients condition from 7 to 14 days
Measurements
quality of life WHOQoL-BREF
body composition bioelectrical impedance analysis BC-420 MA Tanita
weight height and BMI
spirometry Spirometr PNEUMO abcMED
diffusion lung capacity for carbon monoxide LUNGTEST 1000
morphology CRP D-Dimer WBC and gasometry pCO2 pO2
chest computed tomography CT
These parameters will be recorded before the first day of rehabilitation baseline after completion of rehabilitation protocol and three months after completion the rehabilitation protocol A change in evaluated parameters will be assessed
This will be a prospective interventional non-randomized study All patients will be enrolled by Podkarpackie Center for Lung Diseases in Rzeszów
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None